This Unpopular Move Could Save Invitae

It’s been an eventful 30 days for Invitae  (NVTA) . That might be an understatement. The genetic testing pioneer announced a major strategic pivot July 18. The business replaced its CEO, laid of...

Invitae Goes Full Meme Stock. What’s Next?

A little momentum and a big short squeeze can go a long way. Genetic testing platform Invitae  (NVTA)  ripped 277% higher on August 10. It was truly epic. Roughly 217 million shares traded hands. For ...

What’s behind the Invitae stock roller coaster? Morgan Stanley weighs in

Shares of San Francisco-based genetic testing and data company Invitae Corporation (NVTA) exploded higher after reporting earnings Tuesday night. After 6.5 trading hours on Wednesday, Invitae stock ha...

Why I Sold My Invitae Stock

For years I have detested the growth-at-all-costs business models followed by emerging growth companies. They work – until one day (or quarterly update) they don’t. All it takes is one disappoin...